TB-500 Side Effects: A Complete 2026 Guide

TB-500 side effects reported by users tend to be mild and short-lived: soreness at the injection site, a day or two of fatigue or "head fog" early on, mild headache, and a brief flu-like feeling. TB-500 is a synthetic fragment of thymosin beta-4, a protein the body uses to regulate actin, the scaffold cells rely on to migrate and rebuild tissue. The bigger risk in 2026 isn't the peptide. It's buying research-grade vials with no prescriber and no pharmacy behind them.

What are TB-500's side effects?

Most reported TB-500 side effects are mild and temporary. The common ones are redness or soreness at the injection site, short-term tiredness or brain fog in the first week, mild headache, and a light flu-like feeling during the early loading phase. Some people note brief mood or sleep changes. Serious reactions are rarely reported.

TB-500 is a synthetic fragment of a natural protein called thymosin beta-4, which acts on actin to drive cell migration, new blood-vessel growth, and soft-tissue repair. The side-effect picture is drawn from user reports alongside animal studies and human trials of the full-length protein. If you want the fuller picture, start with our TB-500 guide.

What side effects do people report most?

The side effects people mention most are local and short-term. They usually show up early and fade as the body adjusts. None of these are guaranteed, and many users report none at all.

Much of this comes from self-reports, so read it as a general pattern of what people notice. A physician can help you tell a normal adjustment from a reason to stop.

Why does TB-500 cause fatigue?

Fatigue is one of the most common early complaints, and it usually passes. Many users describe a tired, foggy stretch in the first week or two, sometimes called the loading-phase slump. It tends to ease as dosing settles into a lighter maintenance rhythm.

The likely reason ties to how TB-500 works. By acting on actin, it signals cells to migrate and build new blood vessels and soft tissue, and that repair is metabolically busy work the body can feel while it ramps up. If fatigue is heavy or lasts, that's worth flagging to a prescriber rather than pushing through. Dosing choices can matter too, which we cover in the TB-500 dosage guide.

What does the research say about TB-500 safety?

TB-500 is a short 7-amino-acid fragment of thymosin beta-4, and its safety picture draws on the full-length protein it derives from. That protein has been studied in people, and the results point in a reassuring direction.

• Full-length thymosin beta-4 has been tested in people. In Phase 1 studies, healthy volunteers received it intravenously, with reported adverse events mild to moderate and no dose-limiting toxicities or serious adverse events.
• One early Phase 1 program gave healthy adults intravenous doses up to 1,260 mg daily for 14 days without serious adverse events.
• In animals, TB-500 has been dosed roughly from 100 micrograms per kilogram up to 12 milligrams per kilogram across wound, heart, and nerve models without a consistent dose-limiting toxicity.

What are the theoretical risks of TB-500?

A few concerns are raised often. They're theoretical, meaning they come from how the peptide works rather than from confirmed harm in people. They're worth knowing without being alarmed.

• Blood-vessel growth: TB-500 is studied for promoting new blood vessels and cell migration. In theory, that same activity could feed tissue you don't want fed, which is why people with active or past cancer are usually told to avoid it.
• Immune response: as with many peptides, an injected protein fragment could trigger an immune reaction. Regulators list this immunogenicity risk as not fully assessed for TB-500.
• Unknown long-term use: no one has studied years of use in humans, so long-term effects are simply unknown.

None of these are documented as common harms. They're open questions, which is exactly why physician oversight matters.

Is TB-500 safe to use?

TB-500 looks well tolerated in the evidence we have, and reported side effects are mostly mild. The open questions are long-term use in humans and the theoretical risks above, which is why physician oversight matters.

Safety also depends on things that have nothing to do with the molecule: an accurate dose, a clean product, and someone reviewing your health history first. That's the part you can control, and it's where most real-world risk actually lives. See our take on where to buy TB-500 for why sourcing is the deciding factor.

What's the biggest actual risk with TB-500?

It's not the peptide. It's the vial. Today, most TB-500 sold online is research-grade or grey-market, labeled not for human use, with no prescriber and no pharmacy standing behind it. That's where the genuine danger sits.

• No dosing oversight, so it's easy to take too much or mix badly.
• No pharmacy quality control, so purity, sterility, and even the actual contents can be wrong.
• No health screening, so people who should avoid it never find out.
• Mislabeled or under-dosed product is a documented problem in this market.

Who should not use TB-500?

Some people should steer clear or get a physician's sign-off first. This is general information, not medical advice.

• Anyone with active or past cancer, given the blood-vessel-growth theory.
• People who are pregnant or breastfeeding, since there's no safety data.
• Anyone with a serious ongoing health condition or on multiple medications.
• Competitive athletes, because TB-500 is banned by the World Anti-Doping Agency.
• Anyone who can't get a real product through a licensed prescriber and pharmacy.

If you're weighing TB-500 against other options, our best peptides for injury recovery roundup puts it in context.

How does pru approach TB-500?

pru is a telehealth platform. Licensed physicians prescribe, FDA-regulated 503A pharmacies compound and fill, and peptides are priced at cost with a simple membership. You select what interests you, and a physician confirms whether it fits your health. That structure exists to remove exactly the grey-market risk above.

On TB-500 specifically: the FDA removed it from the 503A Category 2 list in April 2026, and the Pharmacy Compounding Advisory Committee reviews it on July 23-24, 2026 to weigh whether it can be compounded through 503A pharmacies. Removal from Category 2 isn't FDA approval and isn't a green light yet. pru is preparing to offer TB-500 the right way, physician-prescribed and 503A-compounded, if and when that pathway opens.

Live today in this recovery lane is GHK-Cu cream, a copper peptide studied for skin and tissue support. You can browse the full repair and regeneration catalog, and membership pricing is on the pricing page. Looking after how your body recovers is a smart, proactive move, and pru exists to make that informed choice the accessible one: licensed physicians, pharmacy-grade product, and at-cost pricing when you are ready to take the next step.

Related reading

• TB-500 guide
• TB-500 benefits
• TB-500 dosage
• BPC-157 and TB-500 stack
• BPC-157 vs TB-500
• Best peptides for injury recovery
• Shop GHK-Cu cream

Common questions